ArticlePLOS global public health2026
"No culture stops me from taking tablets": Exploring community-level factors influencing pregnant women's IPTp-SP uptake in Nigeria.
Article in PLOS global public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nigeria bears the highest burden of malaria cases in the world, and pregnant women are uniquely vulnerable to the disease. Malaria in pregnancy (MiP) may have negative implications for maternal and neonatal health. The World Health Organization (WHO)-recommended intermittent preventive treatment with sulphadoxine-pyrimethamine (IPTp-SP) helps to prevent MiP. However, due to the influence of significant others, the decision-making power regarding health may be outside the purview of pregnant women. Using the social norms theory, this study investigates the role of community factors affecting the use of IPTp-SP among pregnant women. The study adopted qualitative methods, including focus group discussions with pregnant women and in-depth interviews with significant others, including community leaders, traditional birth attendants, religious leaders, spouses and mothers-in-law. Six focus group discussions and seventeen in-depth interviews were conducted with pregnant women and stakeholders, respectively. Data were managed using NVivo (version 12) and analyzed thematically and deductively in line with the social norms theory. We found that most of the pregnant women demonstrated interest in using IPTp-SP. While they recognized the role of significant others in health decision-making, many expressed agency and resistance against social norms opposing their use of IPTp-SP. They exhibited varying degrees of defiance against domination by spouses and mothers-in-law and gave legitimacy to healthcare professionals. Pregnant women and TBAs adopted mixed approaches (traditional and orthodox medicines) to preventing MiP. Pregnant women deferred to their religious leaders than to their community leaders. For this study's sample, descriptive norms were more critical. Most women emphasized their will to make health decisions and prioritized their health and their babies, defying the long-standing social norms that militate against women's health-seeking behaviour.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.